MCX India Share Price Hits 52-Week High on Oct 15, 2025: What’s Contributing to the Gains?

MCX India shares gained on October 15, 2025, reaching a 52-week high amid ongoing investor activity in bullion contracts. 

The stock has gained approximately 15% over the past week, with a one-year return of 45%. Key developments include growth in gold and silver options, new product launches, technological updates, and regulatory developments.

MCX India Stock Performance and Price Details

As of 15th October 2025, 10:30 AM, MCX India shares were trading at ₹9,513.50, up ₹116.00 (1.23%) from the previous close of ₹9,397.50. The stock recorded a day’s high of ₹9,617.00 and a low of ₹9,486.00, with a VWAP of ₹9,546.90.

The stock has shown steady movement over the past week, reflecting investor activity around bullion contracts and derivatives trading.

Growth Drivers and Market Activity

The rise in MCX India shares is supported by multiple factors:

• Bullion Contracts: Increased participation in gold and silver options is expanding revenue streams.
• Product and Technology Developments: New offerings and platform enhancements are contributing to trading volumes.
• Institutional Interest: Upcoming cash-settled index contracts and regulatory developments may encourage institutional participation.
• Revenue and Profit Outlook: MCX’s revenue and profits are expected to grow steadily through FY25-28, supporting current valuation multiples.

MCX Q2 FY26 Results

MCX India’s Board will meet on November 6, 2025, to approve unaudited financial results for the quarter and half-year ending September 30, 2025.

In accordance with SEBI regulations, the trading window for insiders will remain closed until November 9, 2025.

Read More: Gold Rate Today: Check Gold Prices in Your City on Oct 15 – Chennai, Mumbai, Delhi Ahead of Dhanteras 2025.

Conclusion

MCX India shares have risen 6% to a 52-week high on October 15, 2025. Investors are closely monitoring activity in bullion contracts, upcoming cash-settled index offerings, and the board’s scheduled approval of financial results on November 6, 2025.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.